Darolutamide With Docetaxel and ADT Shows OS Benefit in Metastatic Hormone-Sensitive Prostate Cancer
Is triplet therapy the new doublet for metastatic hormone sensitive prostate cancer?
Related Articles
Majority of U.S. Adults Misinformed About Cost of Eating a Plant-Based Diet
Read the full article here
ATOMIC: Adjuvant Chemo Alone, With Atezo for Patients With Stage III dMMR Colon Cancer
Read the full article here
BREAKWATER Trial Shows Practice-Changing Survival Benefit in BRAF V600E–Mutant mCRC
Read the full article here
A fasting-mimicking diet may improve blood sugar control in type 2 diabetes
Read the full article here
Early birds get the burn: Early bedtimes are associated with more physical activity
Read the full article here
Association of tirzepatide with erectile dysfunction in people with type 2 diabetes
Read the full article here